The $1 Million Checkmate: Andrew Left On Mallinckrodt By: Benzinga via Benzinga May 17, 2016 at 14:59 PM EDT Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) spiked on Monday, driven by news that Citron Research's Andrew Left is now ... Read More >> Related Stocks: Mallinckrodt plc Valeant Pharmaceuticals International, Inc.